DEPDC1 and soft tissue sarcoma: The increased expression of the unique RhoGAPs, SDP35/DEDC1A and XPT1/DEPDC1B, is tightly correlated with the metastatic progression of soft-tissue sarcomas, providing compelling evidence for the significant role of aberrant SDP35/DEPDC1A expression as an independent prognostic risk factor (13).